target-profiler

Profile molecular targets for Oral Mucositis druggability and validation evidence.

4|1|Updated Jan 8, 2024

Search Tags:#drug repurposing #network pharmacology #oral mucositis #target profiling #gene-disease mapping #druggability assessment #protein pathway context

Ready to run

npx skills add https://github.com/OpenSourcePharmaFoundation/ospf-ayurveda-kg --skill target-profiler

💬 Prompt for ChatGPT / Claude Chat▼

Please help me install this Agent Skill.
Skill: target-profiler
Source: https://github.com/OpenSourcePharmaFoundation/ospf-ayurveda-kg/tree/main/.claude/skills/target-profiler
Command: npx skills add https://github.com/OpenSourcePharmaFoundation/ospf-ayurveda-kg --skill target-profiler

SYSTEM DOCUMENTATION & REQUIREMENTS

What problem does it solve?

It helps researchers decide whether a specific gene or protein target is a promising, druggable, OM-relevant candidate by assembling validation evidence, pathway context, and known modulators.

Core Features & Use Cases

Single-Target Deep Dive: Build a target profile from OM disease relevance through mechanisms, known drugs, and phytochemical interactions.
Target Comparison & Prioritization: Contrast multiple targets by validation level, druggability, and pathway complementarity for OM treatment.
Network Mapping for OM Context: Identify OM-connected “hub” targets from KG/association data and map them to Sonis OM phases.

Quick Start

Use the target-profiler skill to generate a molecular target profile for TNF-α and rank existing approved drugs and OM-relevant pathway context for Oral Mucositis.

Frequently Asked Questions about target-profiler

High-intent search queries and answers about installing and using this skill.

FAQPage Schema

How do I assess if a molecular target is druggable for oral mucositis treatment?▼

To assess target druggability for oral mucositis, you profile the specified gene or protein by integrating validation evidence, pathway context, and known modulators from repository data. This deep dive evaluates OM relevance across Sonis phases to determine if the target is worth pursuing.

What is network pharmacology mapping for oral mucositis targets?▼

Network pharmacology mapping for oral mucositis identifies OM-connected hub targets from gene-disease association data and maps them to specific Sonis OM phases. It clarifies protein pathway context and reveals target complementarity for drug repurposing workflows.

How do I prioritize multiple gene targets for drug repurposing in oral mucositis?▼

To prioritize gene targets for drug repurposing, you contrast multiple candidates by validation level, druggability, and pathway complementarity. This target comparison ranks approved drugs and phytochemical interactions specific to oral mucositis treatment.

Does target profiling separate known evidence from computational hypotheses?▼

Yes, target profiling separates known evidence from computational hypotheses when generating structured outputs. It references project CSV sources for drug-target, mechanism, and gene-disease associations to clearly distinguish validated biological data from network pharmacology predictions.

Can I use target profiling for drug repurposing without prior repository data?▼

No, target profiling requires project CSV sources containing drug-target, mechanism, and gene-disease associations to build accurate molecular profiles. Repository data is essential for integrating OM relevance, validation evidence, and druggability assessment into the output.